Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel maintains a Buy rating on Dolby Laboratories (NYSE:DLB) with a $98 price target, indicating a positive outlook on the stock.
April 29, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel maintains a Buy rating on Dolby Laboratories with a $98 price target.
The maintenance of a Buy rating and a $98 price target by a Rosenblatt analyst suggests a strong confidence in Dolby Laboratories' future performance. This endorsement is likely to positively influence investor sentiment and could lead to an uptick in the stock's price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100